{"pageContent": "Context: The optimal management of screen-detected, localised prostate cancer remains controversial, related to overtreatment issues of screening and the nonrandomised evidence base. Active surveillance (AS) aims to delay or avoid curative therapy but may potentially harm patients' well-being through living with untreated prostate cancer.", "metaData": {"source": "Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS\nhttps://pubmed.ncbi.nlm.nih.gov/17284382/"}}